
|Videos|May 2, 2021
Investigating the low vulnerability of posterior eye segment to SARS-CoV-2
Author(s)OT Staff Reports
Steffen E. Künzel, MD, discusses the key points of his research presentation regarding low vulnerability of the posterior eye segment to SARS-CoV-2 infection.
Advertisement
Steffen E. Künzel, MD, from the Department of Ophthalmology Charité University Medicine Berlin, Berlin, Germany, discusses the key points of his research presentation on low vulnerability of the posterior eye segment to SARS-CoV-2 infection during the virtual 2021 ARVO meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Treating myopia today: US-focused treatments, challenges, and global insights
2
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
3
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
4